COMIRNATY LP.8.1 30 micrograms/dose dispersion for injection
Authorisation EU/1/20/1528/045-046 · BioNTech Manufacturing GmbH
- Licence holder
- BioNTech Manufacturing GmbH (all products →)
- Dosage form
- Dispersion for injection
- ATC code
- J07BN01
- First authorised
- 21/12/2020
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- New active substance (Article 8(3) of Directive No 2001/83/EC)
About this licence
Centralised EU authorisation. This product holds an EU-wide marketing authorisation granted by the European Commission after assessment by the European Medicines Agency, valid in every EU country. Its EU product number is 1528. It has been authorised for 5 years (since 21 December 2020). The HPRA list does not say whether it is on sale.
Other medicines with Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2 in Ireland
4 other products on the HPRA list contain Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, from 1 licence holder; 0 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| COMIRNATY KP.2 10 micrograms/dose dispersion for injection children 5 to 11 years | BioNTech Manufacturing GmbH | Centralised EU authorisation | Not stated |
| COMIRNATY KP.2 3 micrograms/dose concentrate for dispersion for injection children 6 months to 4 years | BioNTech Manufacturing GmbH | Centralised EU authorisation | Not stated |
| Comirnaty LP.8.1 10 micrograms/dose dispersion for injection | BioNTech Manufacturing GmbH | Centralised EU authorisation | Not stated |
| Comirnaty XFG 30 micrograms/dose dispersion for injection | BioNTech Manufacturing GmbH | Centralised EU authorisation | Not stated |
The licence holder
BioNTech Manufacturing GmbH holds 26 products on the HPRA list, with 6 different active substances; 0 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.